Digesting regulatory guidance is not always easy, but understanding the main points – and then paying attention to the details – will improve your chances of success.

Considering Ebola's impact, how can we incentivize development in other important health areas?

Is the reverse merger between Pfizer and Allergan the most recent chapter in a troubling trend?

Can R&D organizations really afford to kill off analytical data that could be used for future decision-making?

What if biologics and vaccines could be delivered via the buccal or sublingual route?

In-depth analysis of original and new candidate drugs for biosimilars is easier than ever before…

Cell culture media developers used to focus on maximizing protein yield. But yields are yesterday’s problem...

The Medicine Maker Innovation Awards; recognizing the most exciting new technologies of 2015!

Precision medicine holds much promise; are companies up to the challenge?

How do your customers, your competitors, the press or even the public perceive your organization?